Abstract: The present invention provides formulations of anti-LAG3 antibodies, and co-formulations of anti-PD-1 antibodies and anti-LAG3 antibodies, and their use in treating various disorders.
Abstract: The disclosure describes methods for measuring the potency of anti-Respiratory Syncytial Virus (RSV) antibody against respiratory syncytial virus in a cell culture system using an RSV reporter virus. The disclosure also describes respiratory syncytial viruses that carry a reporter gene, and expression vectors for producing an infectious recombinant respiratory syncytial virus (RSV) that carry a reporter gene.
Type:
Application
Filed:
November 8, 2021
Publication date:
December 14, 2023
Applicant:
MERCK SHARP & DOHME LLC
Inventors:
Dai WANG, John P. BILELLO, Kevin B. GURNEY, Ping HAN, Xi HE, Dengyun SUN, Amy Hsu TOU
Abstract: The present invention relates to a method for producing an amorphous solid dispersion of at least one active pharmaceutical ingredient in a polymer matrix. The Invention further relates to a pharmaceutical composition using polymers as an excipient and particularly to an improved pharmaceutical composition comprising polyvinyl alcohol grades with different degrees of hydrolysis, which is suitable to stabilize active pharmaceutical ingredients.
Type:
Application
Filed:
October 20, 2021
Publication date:
December 14, 2023
Applicant:
MERCK PATENT GMBH
Inventors:
Thomas KIPPING, Finn BAUER, Nicole DI GALLO, Anja-Nadine KNUETTEL, Alessandro Giuseppe ELIA
Abstract: Compounds of the following formula (I); or the pharmaceutically acceptable salts thereof, are inhibitors of haematopoietic progenitor kinase 1 (HPK1) useful in the treatment of diseases or disorders associated with HPK1. Also disclosed herein are uses of these compounds in the potential treatment or prevention of an HPK1-associated disease or disorder. Also disclosed herein are compositions comprising one or more of the compounds. Further disclosed herein are uses of these compositions in the potential prevention or treatment of an HPK1-associated disease or disorder.
Type:
Application
Filed:
November 4, 2021
Publication date:
December 14, 2023
Applicant:
MERCK SHARP & DOHME LLC
Inventors:
David A. Candito, Joanna L. Chen, Anthony Donofrio, Xavier Fradera, Peter H. Fuller, Shuhei Kawamura, Bing Li, Jongwon Lim, Ping Liu, Joey L. Methot, Anilkumar G. Nair, Alexander Pasternak, Brandon A. Vara, Elsie C. Yu
Abstract: A switchable window element with a layer structure comprising a switchable layer, two polarizers and two optical retarders; wherein a first polarizer and a first optical retarder are arranged in an optical path prior to the switchable layer and a second polarizer and a second optical retarder are arranged in the optical path after the switchable layer wherein the switchable layer is a vertically aligned liquid crystal layer comprising a liquid crystalline medium and wherein the product of the thickness d of the switchable layer and the optical anisotropy ?n of the liquid crystalline medium is in the range of from 0.05 ?m to 3.0 ?m and the liquid crystalline medium has a clearing point of at least 70° C.
Abstract: The present invention relates to Compounds of Formula I: and pharmaccutically acceptable salts or prodrug thereof. The present invention also relates to compositions comprising at least one compound of Formula I, and methods of using the compounds of Formula I for treatment or prophylaxis of lysosomal storage diseases, neurodegenerative disease, cystic disease, cancer, or a diseases or disorders associated with elevated levels of glucosylceramide (GlcCer), glucosylsphingosine (GlcSph) and/or other glucosylceramide-based glycosphingolipids (GSLs).
Type:
Application
Filed:
September 15, 2021
Publication date:
December 7, 2023
Applicant:
Merck Sharp & Dohme LLC
Inventors:
Michael J. Breslin, Mark E. Fraley, Melissa C. Ford, Kristen L.G. Jones, SR., Anthony J. Roecker, Kathy M. Schirripa, Ling Tong
Abstract: The present invention relates to pharmaceutical compositions using polymers as an excipient. Particularly, the invention relates to a pharmaceutical composition comprising polyvinyl alcohol which is suitable to enhance solubility of poorly soluble active pharmaceutical ingredients in aqueous media. The present invention also relates to a method for enhancing solubility of poorly soluble active pharmaceutical ingredients.
Type:
Application
Filed:
October 27, 2021
Publication date:
December 7, 2023
Applicant:
Merck Patent GmbH
Inventors:
Thomas KIPPING, Finn BAUER, Nicole DI GALLO, Anja-Nadine KNUETTEL, Alessandro Giuseppe ELIA
Abstract: Transfer mechanism/device (40) transferring one or more objects (O) through a transfer port (R), having a supporting base (41), a shuttle (42) with a mount (43) for a holder (47) for the one or more objects (O) or with a holder (47) and a container (44) accommodating the base (41) and the shuttle (42) and accommodating the objects (O), and having at least one opening (45) at an end portion in an axial direction (X) of the container (44).
Abstract: A liquid-crystal (LC) medium based on a mixture of polar compounds, its use for optical, electro-optical and electronic purposes, in particular in LC displays, especially in LC displays of the vertically aligned mode, to an LC display of the vertically aligned mode containing the LC medium, especially an energy-saving LC display and a process of manufacturing the LC display.
Type:
Application
Filed:
June 1, 2023
Publication date:
December 7, 2023
Applicant:
MERCK PATENT GMBH
Inventors:
Harald HIRSCHMANN, Sabine SCHOEN, Philipp WUCHER
Abstract: The present invention relates to a compound of formula T as defined in claim 1, to a liquid crystal medium comprising a compound of formula T and to high-frequency components comprising these media, especially microwave components for high-frequency devices, such as devices for shifting the phase of microwaves, tunable filters, tunable metamaterial structures, and electronic beam steering antennas, e.g. phased array antennas.
Type:
Application
Filed:
October 25, 2021
Publication date:
December 7, 2023
Applicant:
MERCK PATENT GMBH
Inventors:
Amir Hossain PARHAM, Constanze BROCKE, Carsten FRITZSCH, Dagmar KLASS
Abstract: The present application relates to a transport packaging (20) for a plurality of petri-dishes (P), comprising a shell-like main body (21) with a compartment (22) for holding the plurality of petri-dishes (P) in a parallel orientation, the compartment (22) being accessible from an opening (23) at one side of the main body (21), and a rack-like structure (24) formed in the compartment (22) for supporting the petri-dishes (P) in a fixed position during handling and configured to allow insertion/extraction of the petri-dishes (P) into/from the rack-like structure (24) in a direction.
Type:
Application
Filed:
October 20, 2021
Publication date:
December 7, 2023
Applicant:
MERCK PATENT GMBH
Inventors:
Philippe RIVAT, Mathieu ARRAULT, Francois OBLINGER, Stéphane OLIVIER, Gael WAICHE
Abstract: The application relates to a cartridge for a plurality of petri-dishes, comprising a cylindrical cartridge housing configured to receive the plurality of petri-dishes in a stack aligned with an axial direction of the cartridge housing in an interior space of the cartridge housing such that the stack of petri-dishes can be moved in the axial direction within the interior space. An axial end portion of the cartridge housing has a first opening dimensioned so that the petri-dishes can be exposed from the cartridge housing by sliding in the axial direction. Another axial end portion of the cartridge housing has a second opening dimensioned to prevent removal of the petri-dishes through the second opening and so that a piston can be inserted into the interior space of the cartridge housing for moving the stack of petri-dishes (P) in the axial direction towards the first opening.
Abstract: The present disclosure relates to methods of releasing a target molecule from intein complexes comprising an intein-C tagged target molecule and intein-N polypeptides, by contacting the intein complexes with nitrogen containing heteroaromatic derivatives, and/or by increasing residence time of intein complexes in a medium effective to remove the target molecule. Modulating the pH further facilitates target release.
Abstract: The present invention relates to a compound of formula UI as defined in claim 1, to a liquid crystal medium comprising a compound of formula UI and to high-frequency components comprising these media, especially microwave components for high-frequency devices, such as devices for shifting the phase of microwaves, tunable filters, tunable metamaterial structures, and electronic beam steering antennas, e.g. phased array antennas.
Abstract: The present application relates to a transfer device (60) for transferring a plurality of objects (O) through a transfer port (R), comprising a container (61) with an internal space (67) configured to accommodate the plurality of objects (O) to be transferred through the transfer port (R). The container (61) has at least one extraction opening (62) at an end portion of the container (61) in an axial direction (X) dimensioned such that the objects (O) can be removed from the container (61) at least individually, a door (63) configured to selectively close the at least one extraction opening (62) and seal the internal space (67) from the environment, and a piston (64) arranged in the container (61) so as to be movable in a translational motion in the axial direction (X) towards/away from the at least one extraction opening (62) to move the objects (O) accommodated in the container (61).
Abstract: The present invention is directed to macrocyclic urea compounds which are agonists of orexin receptors. The present invention is also directed to uses of the compounds described herein in the potential treatment or prevention of neurological and psychiatric disorders and diseases in which orexin receptors are involved. The present invention is also directed to compositions comprising these compounds. The present invention is also directed to uses of these compositions in the potential prevention or treatment of such diseases in which orexin receptors are involved.
Type:
Application
Filed:
October 28, 2021
Publication date:
December 7, 2023
Applicant:
Merck Sharp & Dohme LLC
Inventors:
Kira A. Armacost, Maria Irina Chiriac, Danielle M. Hurzy, Jeffrey C. Kern, Jian Liu, Peter J. Manley, Vanessa L. Rada, Michael T. Rudd, Craig A. Stump, Zhe Wu, Dong Xiao
Abstract: The present application relates to a rack (1) for holding a plurality of petri-dishes (P), comprising a plate-like main body (2) with a plurality of adjacent and spaced apart holding portions (3) each configured to receive and support, in a substantially horizontal orientation that is substantially perpendicular to a plane of the plate-like main body (2), a petri-dish (P), wherein each holding portion (3) includes positioning features (4) for positioning the petri-dish (P) in the holding portion (3).
Abstract: The present invention relates to a polymerizable mixture which can be used to form a dielectric material for the preparation of passivation layers in electronic devices. The polymerizable mixture comprises a first monomer and a second monomer which may react to form a copolymer providing excellent film forming capability, excellent thermal properties and excellent mechanical properties. There is further provided a method for forming said copolymers and an electronic device containing said copolymers as dielectric material. Beyond that, the present invention relates to a manufacturing method for preparing a packaged microelectronic structure and to a microelectronic device comprising said packaged microelectronic structure formed by said manufacturing method.
Type:
Grant
Filed:
October 15, 2019
Date of Patent:
December 5, 2023
Assignee:
Merck Patent GmbH
Inventors:
Gregor Larbig, Pawel Miskiewicz, Frank Meyer, Joerg Pahnke, Karsten Koppe